Replies to post #87783 on Biotech Values

[DewDiligence]

CYCC:

The president tried to counter this by saying that sapacitabine has the potential to transform AML into more of a chronic disease and I implied that to mean more patient time on drug equates to a much bigger revenue opportunity…

Sorry for the nitpick but you meant inferred, not implied :- )